T-wave reversal in the augmented unipolar right arm electrocardiographic lead is associated with increased risk of sudden death
- PMID: 26628059
- PMCID: PMC5624711
- DOI: 10.1007/s10840-015-0078-1
T-wave reversal in the augmented unipolar right arm electrocardiographic lead is associated with increased risk of sudden death
Abstract
Background: Repolarization abnormalities are associated with ventricular arrhythmias, and published studies report that a reversal of T wave polarity (positive or flat T wave) in lead aVR may be linked to increased cardiovascular mortality. We evaluated whether a positive or flat T wave in aVR is a risk marker for sudden cardiac death (SCD).
Methods: SCD cases from the Oregon Sudden Unexpected Death Study (catchment population ~1 million) were compared to geographic controls with coronary artery disease and no history of SCD. Archived electrocardiograms performed prior and unrelated to the SCD event were evaluated.
Results: SCD cases (n = 691, 67.6 ± 14.9 years, 69% male) were more likely than controls (n = 663, 66.2 ± 11.6 years, 67% male) to have diabetes (40 vs 32%; p < 0.01), left ventricular ejection fraction (LVEF) ≤35% (27 vs 11 %; p < 0.01), prolonged QTc (≥450 ms; 54 vs 28%; p < 0.01) and positive (19 vs 13%; p < 0.01) or flat T wave (14 vs 7%; p < 0.01) in aVR. On multivariable analysis, a positive/flat T wave in aVR was independently associated with SCD (OR 1.9, 95% CI 1.3-2.8, p < 0.01). However, a positive T wave alone lost statistical significance in patients with LVEF ≤ 35% and QTc ≥ 450 ms. In a subgroup analysis among patients with normal LVEF, QTc, and no diabetes, a positive T wave in aVR (but not a flat T wave) remained associated with SCD (OR 2.8, 95% CI 1.2-6.1, p < 0.01).
Conclusions: A positive or flat T wave in lead aVR was associated with SCD in subsets of patients. This simple ECG marker in this often-ignored lead may contribute to enhancement of SCD risk stratification, and warrants further evaluation.
Keywords: Electrocardiography; Lead aVR; Risk stratification; Sudden cardiac death.
Figures
Similar articles
-
Cardiac structural and functional profile of patients with delayed QRS transition zone and sudden cardiac death.Europace. 2017 Apr 1;19(4):629-635. doi: 10.1093/europace/euw040. Europace. 2017. PMID: 28431059
-
QRS fragmentation and sudden cardiac death in the obese and overweight.J Am Heart Assoc. 2015 Mar 11;4(3):e001654. doi: 10.1161/JAHA.114.001654. J Am Heart Assoc. 2015. PMID: 25762804 Free PMC article.
-
Non-invasive risk stratification for sudden cardiac death by heart rate turbulence and microvolt T-wave alternans in patients after myocardial infarction.Europace. 2012 Dec;14(12):1786-92. doi: 10.1093/europace/eus238. Epub 2012 Jul 31. Europace. 2012. PMID: 22849973
-
Electrocardiographic T Wave Abnormalities and the Risk of Sudden Cardiac Death: The Finnish Perspective.Ann Noninvasive Electrocardiol. 2015 Nov;20(6):526-33. doi: 10.1111/anec.12310. Epub 2015 Sep 22. Ann Noninvasive Electrocardiol. 2015. PMID: 26391699 Free PMC article. Review.
-
Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death?Eur Heart J. 2013 Jul;34(26):1964-71. doi: 10.1093/eurheartj/eht109. Epub 2013 May 3. Eur Heart J. 2013. PMID: 23644180 Review.
Cited by
-
T wave positivity in lead aVR is associated with mortality in patients with cardiac resynchronization therapy.J Interv Card Electrophysiol. 2018 Oct;53(1):41-46. doi: 10.1007/s10840-018-0364-9. Epub 2018 Apr 8. J Interv Card Electrophysiol. 2018. PMID: 29627955
-
Evaluating of Red Blood Cell Distribution Width, Comorbidities and Electrocardiographic Ratios as Predictors of Prognosis in Patients with Pulmonary Hypertension.Diagnostics (Basel). 2021 Jul 20;11(7):1297. doi: 10.3390/diagnostics11071297. Diagnostics (Basel). 2021. PMID: 34359380 Free PMC article.
References
-
- Go AS, Mozaffarian D, Roger VL, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics–2014 update: a report from the American Heart Association. Circulation. 2014 Jan 21;129(3):e28–e292. doi: 10.1161/01.cir.0000441139.02102.80. Epub 2013 Dec 18. - DOI - PMC - PubMed
-
- Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005 Jan 20;352(3):225–37. - PubMed
-
- Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, Multicenter Automatic Defibrillator Implantation Trial II Investigators Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002 Mar 21;346(12):877–83. Epub 2002 Mar 19. - PubMed
-
- Stecker EC, Vickers C, Waltz J, Socoteanu C, John BT, Mariani R, McAnulty JH, Gunson K, Jui J, Chugh SS. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. J Am Coll Cardiol. 2006 Mar 21;47(6):1161–6. Epub 2006 Feb 23. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical